O	O	0	5	Human	Human	B-NP	JJ	O	10	NMOD	O
O	O	6	7	T	T	I-NP	NN	O	10	NMOD	O
O	O	7	8	-	-	I-NP	HYPH	O	10	NMOD	O
O	O	8	12	cell	cell	I-NP	NN	O	10	NMOD	O
O	O	13	21	leukemia	leukemia	I-NP	NN	O	10	NMOD	O
O	O	22	27	virus	virus	I-NP	NN	O	10	NMOD	O
O	O	28	32	type	type	I-NP	NN	O	10	NMOD	O
O	O	33	34	1	1	I-NP	CD	O	10	NMOD	O
T1	B-Protein	35	38	Tax	Tax	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	39	48	induction	induction	I-NP	NN	O	15	SUB	O
O	O	49	51	of	of	B-PP	IN	O	10	NMOD	O
T33	B-Entity	52	54	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T33	I-Entity	54	55	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T33	I-Entity	55	61	kappaB	kappaB	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	62	70	involves	involve	B-VP	VBZ	O	0	ROOT	O
O	O	71	81	activation	activation	B-NP	NN	O	15	OBJ	O
O	O	82	84	of	of	B-PP	IN	O	16	NMOD	O
O	O	85	88	the	the	B-NP	DT	O	21	NMOD	O
T2	B-Protein	89	96	IkappaB	IkappaB	I-NP	NN	B-protein	21	NMOD	B-protein
T2	I-Protein	97	103	kinase	kinase	I-NP	NN	I-protein	21	NMOD	I-protein
T2	I-Protein	104	109	alpha	alpha	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	110	111	(	(	O	(	O	24	DEP	O
T3	B-Protein	111	119	IKKalpha	IKKalpha	B-NP	NN	B-protein	24	DEP	B-protein
O	O	119	120	)	)	O	)	O	21	NMOD	O
O	O	121	124	and	and	O	CC	O	28	NMOD	O
T4	B-Protein	125	132	IKKbeta	IKKbeta	B-NP	NN	B-protein	28	NMOD	B-protein
O	O	133	141	cellular	cellular	I-NP	JJ	B-protein	28	NMOD	B-protein
O	O	142	149	kinases	kinase	I-NP	NNS	I-protein	17	PMOD	I-protein
O	O	149	150	.	.	O	.	O	15	P	O

T5	B-Protein	152	155	Tax	Tax	B-NP	NN	B-protein	2	SUB	B-protein
O	O	156	167	corresponds	correspond	B-VP	VBZ	O	0	ROOT	O
O	O	168	170	to	to	B-PP	TO	O	2	VMOD	O
O	O	171	172	a	a	B-NP	DT	O	9	NMOD	O
O	O	173	175	40	40	I-NP	CD	B-protein	9	NMOD	B-protein
O	O	175	176	-	-	I-NP	HYPH	I-protein	9	P	I-protein
O	O	176	179	kDa	kDa	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	180	192	transforming	transform	B-VP	VBG	I-protein	9	NMOD	I-protein
O	O	193	200	protein	protein	B-NP	NN	I-protein	3	PMOD	I-protein
O	O	201	205	from	from	B-PP	IN	O	9	NMOD	O
O	O	206	209	the	the	B-NP	DT	O	10	PMOD	O
O	O	210	220	pathogenic	pathogenic	I-NP	JJ	O	11	NMOD	O
O	O	221	231	retrovirus	retrovirus	I-NP	NN	O	12	OBJ	O
O	O	232	237	human	human	I-NP	JJ	O	13	NMOD	O
O	O	238	239	T	T	I-NP	NN	O	14	PMOD	O
O	O	239	240	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	240	244	cell	cell	I-NP	NN	O	20	NMOD	O
O	O	245	253	leukemia	leukemia	I-NP	NN	O	20	NMOD	O
O	O	254	259	virus	virus	I-NP	NN	O	20	NMOD	O
O	O	260	264	type	type	I-NP	NN	O	16	PMOD	O
O	O	265	266	1	1	I-NP	CD	O	20	NMOD	O
O	O	267	268	(	(	O	(	O	26	DEP	O
O	O	268	272	HTLV	HTLV	B-NP	NN	O	26	DEP	O
O	O	272	273	-	-	B-NP	HYPH	O	23	P	O
O	O	273	274	1	1	I-NP	CD	O	23	NMOD	O
O	O	274	275	)	)	O	)	O	20	NMOD	O
O	O	276	280	that	that	B-NP	WDT	O	20	NMOD	O
O	O	281	290	activates	activate	B-VP	VBZ	O	27	SBAR	O
O	O	291	298	nuclear	nuclear	B-NP	JJ	O	30	NMOD	O
O	O	299	309	expression	expression	I-NP	NN	O	28	OBJ	O
O	O	310	312	of	of	B-PP	IN	O	30	NMOD	O
O	O	313	316	the	the	B-NP	DT	O	38	NMOD	O
T34	B-Entity	317	319	NF	NF	I-NP	NN	B-protein	35	NMOD	B-protein
T34	I-Entity	319	320	-	-	B-NP	HYPH	I-protein	35	P	I-protein
T34	I-Entity	320	326	kappaB	kappaB	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	326	327	/	/	I-NP	SYM	O	38	P	O
O	O	327	330	Rel	Rel	I-NP	NN	B-protein	38	NMOD	B-protein
O	O	331	337	family	family	I-NP	NN	I-protein	31	PMOD	I-protein
O	O	338	340	of	of	B-PP	IN	O	38	NMOD	O
O	O	341	354	transcription	transcription	B-NP	NN	B-protein	41	NMOD	B-protein
O	O	355	362	factors	factor	I-NP	NNS	I-protein	39	PMOD	I-protein
O	O	363	365	by	by	B-PP	IN	O	28	VMOD	O
O	O	366	368	an	an	B-NP	DT	O	45	NMOD	O
O	O	369	376	unknown	unknown	I-NP	JJ	O	45	NMOD	O
O	O	377	386	mechanism	mechanism	I-NP	NN	O	42	PMOD	O
O	O	386	387	.	.	O	.	O	2	P	O

T6	B-Protein	388	391	Tax	Tax	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	392	402	expression	expression	I-NP	NN	O	3	SUB	O
O	O	403	411	promotes	promote	B-VP	VBZ	O	0	ROOT	O
T35	B-Entity	412	413	N	N	B-NP	NN	O	9	NMOD	O
T35	I-Entity	413	414	-	-	B-NP	HYPH	O	9	NMOD	O
T35	I-Entity	414	422	terminal	terminal	I-NP	JJ	O	9	NMOD	O
O	O	423	438	phosphorylation	phosphorylation	I-NP	NN	O	9	NMOD	O
O	O	439	442	and	and	I-NP	CC	O	9	NMOD	O
O	O	443	454	degradation	degradation	I-NP	NN	O	3	OBJ	O
O	O	455	457	of	of	B-PP	IN	O	9	NMOD	O
T7	B-Protein	458	465	IkappaB	IkappaB	B-NP	NN	B-protein	12	NMOD	B-protein
T7	I-Protein	466	471	alpha	alpha	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	471	472	,	,	O	,	O	17	P	O
O	O	473	474	a	a	B-NP	DT	O	17	NMOD	O
O	O	475	484	principal	principal	I-NP	JJ	O	17	NMOD	O
O	O	485	496	cytoplasmic	cytoplasmic	I-NP	JJ	O	17	NMOD	O
O	O	497	506	inhibitor	inhibitor	I-NP	NN	O	10	PMOD	O
O	O	507	509	of	of	B-PP	IN	O	17	NMOD	O
T36	B-Entity	510	512	NF	NF	B-NP	NN	B-protein	21	NMOD	B-protein
T36	I-Entity	512	513	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T36	I-Entity	513	519	kappaB	kappaB	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	519	520	.	.	O	.	O	3	P	O

O	O	521	524	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	525	532	studies	study	I-NP	NNS	O	4	SUB	O
O	O	533	536	now	now	B-ADVP	RB	O	4	VMOD	O
O	O	537	548	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	549	553	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	554	558	HTLV	HTLV	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	558	559	-	-	B-NP	HYPH	O	9	NMOD	O
O	O	559	560	1	1	I-NP	CD	O	9	NMOD	O
T8	B-Protein	561	564	Tax	Tax	I-NP	NN	B-protein	10	SUB	B-protein
O	O	565	574	activates	activate	B-VP	VBZ	O	5	SBAR	O
O	O	575	578	the	the	B-NP	DT	O	15	NMOD	O
O	O	579	587	recently	recently	I-NP	RB	O	13	AMOD	O
O	O	588	598	identified	identify	I-NP	VBN	O	15	NMOD	O
O	O	599	607	cellular	cellular	I-NP	JJ	B-protein	15	NMOD	B-protein
O	O	608	615	kinases	kinase	I-NP	NNS	I-protein	23	NMOD	I-protein
T9	B-Protein	616	623	IkappaB	IkappaB	I-NP	NN	B-protein	18	NMOD	B-protein
T9	I-Protein	624	630	kinase	kinase	I-NP	NN	I-protein	18	NMOD	I-protein
T9	I-Protein	631	636	alpha	alpha	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	637	638	(	(	O	(	O	21	DEP	O
T10	B-Protein	638	646	IKKalpha	IKKalpha	B-NP	NN	B-protein	21	DEP	B-protein
O	O	646	647	)	)	O	)	O	18	NMOD	O
O	O	648	651	and	and	O	CC	O	23	NMOD	O
T11	B-Protein	652	659	IKKbeta	IKKbeta	B-NP	NN	B-protein	10	OBJ	B-protein
O	O	659	660	,	,	O	,	O	23	P	O
O	O	661	666	which	which	B-NP	WDT	O	23	NMOD	O
O	O	667	675	normally	normally	B-ADVP	RB	O	27	VMOD	O
O	O	676	689	phosphorylate	phosphorylate	B-VP	VBP	O	25	SBAR	O
T12	B-Protein	690	697	IkappaB	IkappaB	B-NP	NN	B-protein	29	NMOD	B-protein
T12	I-Protein	698	703	alpha	alpha	I-NP	NN	I-protein	27	OBJ	I-protein
O	O	704	706	on	on	B-PP	IN	O	27	VMOD	O
O	O	707	711	both	both	B-NP	DT	O	30	PMOD	O
O	O	712	714	of	of	B-PP	IN	O	31	NMOD	O
O	O	715	718	its	its	B-NP	PRP$	O	38	NMOD	O
T37	B-Entity	719	720	N	N	I-NP	NN	O	38	NMOD	O
T37	I-Entity	720	721	-	-	I-NP	HYPH	O	38	P	O
T37	I-Entity	721	729	terminal	terminal	I-NP	JJ	O	38	NMOD	O
T37	I-Entity	730	740	regulatory	regulatory	I-NP	JJ	O	38	NMOD	O
T37	I-Entity	741	748	serines	serine	I-NP	NNS	O	32	PMOD	O
O	O	749	751	in	in	B-PP	IN	O	27	VMOD	O
O	O	752	760	response	response	B-NP	NN	O	39	PMOD	O
O	O	761	763	to	to	B-PP	TO	O	40	NMOD	O
T13	B-Protein	764	769	tumor	tumor	B-NP	NN	B-protein	45	NMOD	B-protein
T13	I-Protein	770	778	necrosis	necrosis	I-NP	NN	I-protein	45	NMOD	I-protein
T13	I-Protein	779	785	factor	factor	I-NP	NN	I-protein	45	NMOD	I-protein
T13	I-Protein	786	791	alpha	alpha	I-NP	NN	I-protein	60	NMOD	I-protein
O	O	792	793	(	(	O	(	O	50	DEP	O
T14	B-Protein	793	796	TNF	TNF	B-NP	NN	B-protein	49	NMOD	B-protein
T14	I-Protein	796	797	-	-	O	HYPH	I-protein	49	P	I-protein
T14	I-Protein	797	802	alpha	alpha	B-NP	SYM	I-protein	50	DEP	I-protein
O	O	802	803	)	)	O	)	O	45	NMOD	O
O	O	804	807	and	and	O	CC	O	60	NMOD	O
O	O	808	819	interleukin	interleukin	B-NP	NN	B-protein	53	NMOD	B-protein
O	O	819	820	-	-	B-NP	HYPH	I-protein	60	NMOD	I-protein
O	O	820	821	1	1	I-NP	CD	I-protein	53	NMOD	I-protein
O	O	822	823	(	(	O	(	O	59	DEP	O
O	O	823	825	IL	IL	O	NN	B-protein	58	VMOD	B-protein
O	O	825	826	-	-	O	HYPH	I-protein	58	P	I-protein
O	O	826	827	1	1	O	CD	I-protein	59	DEP	I-protein
O	O	827	828	)	)	O	)	O	53	NMOD	O
O	O	829	840	stimulation	stimulation	B-NP	NN	O	41	PMOD	O
O	O	840	841	.	.	O	.	O	4	P	O

O	O	842	844	In	In	B-PP	IN	O	19	VMOD	O
O	O	845	853	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	853	854	,	,	O	,	O	19	P	O
O	O	855	856	a	a	B-NP	DT	O	5	NMOD	O
O	O	857	863	mutant	mutant	I-NP	NN	O	19	SUB	O
O	O	864	866	of	of	B-PP	IN	O	5	NMOD	O
T15	B-Protein	867	870	Tax	Tax	B-NP	NN	B-protein	6	PMOD	B-protein
O	O	871	877	termed	term	I-NP	VBN	O	7	NMOD	O
O	O	878	881	M22	M22	I-NP	NN	B-protein	8	VMOD	B-protein
O	O	881	882	,	,	O	,	O	5	P	O
O	O	883	888	which	which	B-NP	WDT	O	5	NMOD	O
O	O	889	893	does	do	B-VP	VBZ	O	11	SBAR	O
O	O	894	897	not	not	I-VP	RB	O	12	VMOD	O
O	O	898	904	induce	induce	I-VP	VB	O	12	VC	O
T38	B-Entity	905	907	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T38	I-Entity	907	908	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T38	I-Entity	908	914	kappaB	kappaB	I-NP	NN	I-protein	14	OBJ	I-protein
O	O	914	915	,	,	O	,	O	19	P	O
O	O	916	921	fails	fail	B-VP	VBZ	O	0	ROOT	O
O	O	922	924	to	to	I-VP	TO	O	21	VMOD	O
O	O	925	933	activate	activate	I-VP	VB	O	19	VMOD	O
O	O	934	940	either	either	O	CC	O	25	NMOD	O
T16	B-Protein	941	949	IKKalpha	IKKalpha	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	950	952	or	or	I-NP	CC	O	25	NMOD	O
T17	B-Protein	953	960	IKKbeta	IKKbeta	I-NP	NN	B-protein	21	OBJ	B-protein
O	O	960	961	.	.	O	.	O	19	P	O

O	O	962	973	Furthermore	Furthermore	B-ADVP	RB	O	7	VMOD	O
O	O	973	974	,	,	O	,	O	7	P	O
O	O	975	985	endogenous	endogenous	B-NP	JJ	O	6	NMOD	O
O	O	986	989	IKK	IKK	I-NP	NN	O	6	NMOD	O
O	O	990	999	enzymatic	enzymatic	I-NP	JJ	O	6	NMOD	O
O	O	1000	1008	activity	activity	I-NP	NN	O	7	SUB	O
O	O	1009	1012	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1013	1026	significantly	significantly	I-VP	RB	O	7	VMOD	O
O	O	1027	1035	elevated	elevate	I-VP	VBN	O	7	VC	O
O	O	1036	1038	in	in	B-PP	IN	O	9	VMOD	O
O	O	1039	1043	HTLV	HTLV	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	1043	1044	-	-	B-NP	HYPH	O	13	P	O
O	O	1044	1045	1	1	I-NP	CD	O	10	PMOD	O
O	O	1045	1046	-	-	O	HYPH	O	15	AMOD	O
O	O	1046	1054	infected	infect	B-VP	VBN	O	13	NMOD	O
O	O	1055	1058	and	and	O	CC	O	23	NMOD	O
T18	B-Protein	1059	1062	Tax	Tax	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	1062	1063	-	-	B-VP	HYPH	O	23	P	O
O	O	1063	1073	expressing	express	B-NP	VBG	O	23	NMOD	O
O	O	1074	1075	T	T	I-NP	NN	B-cell_line	23	NMOD	B-cell_line
O	O	1075	1076	-	-	I-NP	HYPH	I-cell_line	23	NMOD	I-cell_line
O	O	1076	1080	cell	cell	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	1081	1086	lines	line	I-NP	NNS	I-cell_line	13	NMOD	I-cell_line
O	O	1086	1087	.	.	O	.	O	7	P	O

O	O	1088	1100	Transfection	Transfection	B-NP	NN	O	20	SUB	O
O	O	1101	1103	of	of	B-PP	IN	O	1	NMOD	O
O	O	1104	1110	kinase	kinase	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	1110	1111	-	-	B-NP	HYPH	O	6	NMOD	O
O	O	1111	1120	deficient	deficient	I-NP	JJ	O	6	NMOD	O
O	O	1121	1128	mutants	mutant	I-NP	NNS	O	2	PMOD	O
O	O	1129	1131	of	of	B-PP	IN	O	6	NMOD	O
T19	B-Protein	1132	1140	IKKalpha	IKKalpha	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	1141	1144	and	and	I-NP	CC	O	10	NMOD	O
T20	B-Protein	1145	1152	IKKbeta	IKKbeta	I-NP	NN	B-protein	7	PMOD	B-protein
O	O	1153	1157	into	into	B-PP	IN	O	1	NMOD	O
O	O	1158	1164	either	either	B-NP	CC	O	18	NMOD	O
O	O	1165	1170	human	human	I-NP	JJ	B-cell_line	15	NMOD	B-cell_line
O	O	1171	1177	Jurkat	Jurkat	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	1178	1179	T	T	I-NP	NN	I-cell_line	18	NMOD	I-cell_line
O	O	1180	1182	or	or	O	CC	I-cell_line	18	NMOD	I-cell_line
O	O	1183	1186	293	293	B-NP	CD	I-cell_line	18	NMOD	I-cell_line
O	O	1187	1192	cells	cell	I-NP	NNS	I-cell_line	11	PMOD	I-cell_line
O	O	1193	1197	also	also	B-ADVP	RB	O	20	VMOD	O
O	O	1198	1206	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
T39	B-Entity	1207	1209	NF	NF	B-NP	NN	B-protein	23	NMOD	B-protein
T39	I-Entity	1209	1210	-	-	I-NP	HYPH	I-protein	23	P	I-protein
T39	I-Entity	1210	1216	kappaB	kappaB	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1216	1217	-	-	I-NP	HYPH	O	28	NMOD	O
O	O	1217	1226	dependent	dependent	I-NP	JJ	O	28	NMOD	O
T40	B-Entity	1227	1235	reporter	reporter	I-NP	NN	B-DNA	28	NMOD	B-DNA
T40	I-Entity	1236	1240	gene	gene	I-NP	NN	I-DNA	28	NMOD	I-DNA
O	O	1241	1251	expression	expression	I-NP	NN	O	20	OBJ	O
O	O	1252	1259	induced	induce	B-VP	VBN	O	28	NMOD	O
O	O	1260	1262	by	by	B-PP	IN	O	29	VMOD	O
T21	B-Protein	1263	1266	Tax	Tax	B-NP	NN	B-protein	30	PMOD	B-protein
O	O	1266	1267	.	.	O	.	O	20	P	O

O	O	1268	1277	Similarly	Similarly	B-ADVP	RB	O	42	VMOD	O
O	O	1277	1278	,	,	O	,	O	42	P	O
O	O	1279	1280	a	a	B-NP	DT	O	7	NMOD	O
O	O	1281	1287	kinase	kinase	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	1287	1288	-	-	B-NP	HYPH	O	7	NMOD	O
O	O	1288	1297	deficient	deficient	I-NP	JJ	O	7	NMOD	O
O	O	1298	1304	mutant	mutant	I-NP	NN	O	42	SUB	O
O	O	1305	1307	of	of	B-PP	IN	O	7	NMOD	O
T22	B-Protein	1308	1311	NIK	NIK	B-NP	NN	B-protein	8	PMOD	B-protein
O	O	1312	1313	(	(	O	(	O	17	DEP	O
T23	B-Protein	1313	1315	NF	NF	B-NP	NN	B-protein	13	NMOD	B-protein
T23	I-Protein	1315	1316	-	-	B-NP	HYPH	I-protein	13	NMOD	I-protein
T23	I-Protein	1316	1322	kappaB	kappaB	I-NP	NN	I-protein	17	DEP	I-protein
T23	I-Protein	1322	1323	-	-	O	HYPH	O	13	P	O
T23	I-Protein	1323	1331	inducing	induce	B-VP	VBG	O	13	NMOD	O
T23	I-Protein	1332	1338	kinase	kinase	B-NP	NN	O	15	OBJ	O
O	O	1338	1339	)	)	O	)	O	9	NMOD	O
O	O	1339	1340	,	,	O	,	O	7	P	O
O	O	1341	1346	which	which	B-NP	WDT	O	7	NMOD	O
O	O	1347	1357	represents	represent	B-VP	VBZ	O	19	SBAR	O
O	O	1358	1360	an	an	B-NP	DT	O	23	NMOD	O
O	O	1361	1369	upstream	upstream	I-NP	JJ	B-protein	23	NMOD	B-protein
O	O	1370	1376	kinase	kinase	I-NP	NN	I-protein	20	OBJ	I-protein
O	O	1377	1379	in	in	B-PP	IN	O	20	VMOD	O
O	O	1380	1383	the	the	B-NP	DT	O	34	NMOD	O
T24	B-Protein	1384	1387	TNF	TNF	I-NP	NN	B-protein	34	NMOD	B-protein
T24	I-Protein	1387	1388	-	-	O	HYPH	O	34	P	O
T24	I-Protein	1388	1393	alpha	alpha	B-NP	SYM	O	34	NMOD	O
O	O	1394	1397	and	and	O	CC	O	34	NMOD	O
O	O	1398	1400	IL	IL	B-NP	NN	B-protein	31	NMOD	B-protein
O	O	1400	1401	-	-	B-NP	HYPH	I-protein	34	NMOD	I-protein
O	O	1401	1402	1	1	I-NP	CD	I-protein	31	NMOD	I-protein
O	O	1403	1412	signaling	signaling	I-NP	NN	O	34	NMOD	O
O	O	1413	1421	pathways	pathway	I-NP	NNS	O	24	PMOD	O
O	O	1422	1429	leading	lead	B-VP	VBG	O	34	NMOD	O
O	O	1430	1432	to	to	B-PP	TO	O	35	VMOD	O
T25	B-Protein	1433	1441	IKKalpha	IKKalpha	B-NP	NN	B-protein	40	NMOD	B-protein
O	O	1442	1445	and	and	I-NP	CC	O	40	NMOD	O
T26	B-Protein	1446	1453	IKKbeta	IKKbeta	I-NP	NN	B-protein	40	NMOD	B-protein
O	O	1454	1464	activation	activation	I-NP	NN	O	36	PMOD	O
O	O	1464	1465	,	,	O	,	O	42	P	O
O	O	1466	1472	blocks	block	B-VP	VBZ	O	0	ROOT	O
T27	B-Protein	1473	1476	Tax	Tax	B-NP	NN	B-protein	44	NMOD	B-protein
O	O	1477	1486	induction	induction	I-NP	NN	O	42	OBJ	O
O	O	1487	1489	of	of	B-PP	IN	O	44	NMOD	O
T41	B-Entity	1490	1492	NF	NF	B-NP	NN	B-protein	48	NMOD	B-protein
T41	I-Entity	1492	1493	-	-	B-NP	HYPH	I-protein	48	NMOD	I-protein
T41	I-Entity	1493	1499	kappaB	kappaB	I-NP	NN	I-protein	45	PMOD	I-protein
O	O	1499	1500	.	.	O	.	O	42	P	O

O	O	1501	1508	However	However	B-ADVP	RB	O	13	VMOD	O
O	O	1508	1509	,	,	O	,	O	13	P	O
T42	B-Entity	1510	1516	plasma	plasma	B-NP	NN	B-DNA	7	NMOD	B-DNA
T42	I-Entity	1517	1525	membrane	membrane	I-NP	NN	I-DNA	3	NMOD	I-DNA
T42	I-Entity	1525	1526	-	-	B-NP	HYPH	I-DNA	7	NMOD	I-DNA
T42	I-Entity	1526	1534	proximal	proximal	I-NP	JJ	I-DNA	7	NMOD	I-DNA
T42	I-Entity	1535	1543	elements	element	I-NP	NNS	I-DNA	13	SUB	I-DNA
O	O	1544	1546	in	in	B-PP	IN	O	7	NMOD	O
O	O	1547	1552	these	these	B-NP	DT	O	12	NMOD	O
O	O	1553	1568	proinflammatory	proinflammatory	I-NP	JJ	B-protein	12	NMOD	B-protein
O	O	1569	1577	cytokine	cytokine	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	1578	1586	pathways	pathway	I-NP	NNS	O	8	PMOD	O
O	O	1587	1590	are	be	B-VP	VBP	O	0	ROOT	O
O	O	1591	1601	apparently	apparently	I-VP	RB	O	13	VMOD	O
O	O	1602	1605	not	not	I-VP	RB	O	13	VMOD	O
O	O	1606	1614	involved	involve	I-VP	VBN	O	13	VC	O
O	O	1615	1620	since	since	B-PP	IN	O	16	VMOD	O
O	O	1621	1629	dominant	dominant	B-NP	JJ	B-protein	20	NMOD	B-protein
O	O	1630	1638	negative	negative	I-NP	JJ	I-protein	20	NMOD	I-protein
O	O	1639	1646	mutants	mutant	I-NP	NNS	I-protein	17	PMOD	I-protein
O	O	1647	1649	of	of	B-PP	IN	O	20	NMOD	O
O	O	1650	1653	the	the	B-NP	DT	O	26	NMOD	O
T28	B-Protein	1654	1659	TRAF2	TRAF2	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	1660	1663	and	and	I-NP	CC	O	26	NMOD	O
T29	B-Protein	1664	1669	TRAF6	TRAF6	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	1670	1678	adaptors	adaptor	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	1678	1679	,	,	O	,	O	20	P	O
O	O	1680	1685	which	which	B-NP	WDT	O	20	NMOD	O
O	O	1686	1697	effectively	effectively	B-ADVP	RB	O	30	VMOD	O
O	O	1698	1703	block	block	B-VP	VBP	O	28	SBAR	O
O	O	1704	1713	signaling	signal	I-VP	VBG	O	30	OBJ	O
O	O	1714	1721	through	through	B-PP	IN	O	30	VMOD	O
O	O	1722	1725	the	the	B-NP	DT	O	35	NMOD	O
O	O	1726	1737	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	35	NMOD	B-protein
O	O	1738	1743	tails	tail	I-NP	NNS	I-protein	32	PMOD	I-protein
O	O	1744	1746	of	of	B-PP	IN	O	35	NMOD	O
O	O	1747	1750	the	the	B-NP	DT	O	45	NMOD	O
O	O	1751	1754	TNF	TNF	I-NP	NN	B-protein	45	NMOD	B-protein
O	O	1754	1755	-	-	O	HYPH	O	45	NMOD	O
O	O	1755	1760	alpha	alpha	B-NP	SYM	O	45	NMOD	O
O	O	1761	1764	and	and	O	CC	O	45	NMOD	O
O	O	1765	1767	IL	IL	B-NP	NN	B-protein	45	NMOD	B-protein
O	O	1767	1768	-	-	B-NP	HYPH	I-protein	45	NMOD	I-protein
O	O	1768	1769	1	1	I-NP	CD	I-protein	45	NMOD	I-protein
O	O	1770	1779	receptors	receptor	I-NP	NNS	I-protein	36	PMOD	I-protein
O	O	1779	1780	,	,	O	,	O	30	P	O
O	O	1781	1793	respectively	respectively	B-ADVP	RB	O	30	VMOD	O
O	O	1793	1794	,	,	O	,	O	30	P	O
O	O	1795	1797	do	do	B-VP	VBP	O	30	VMOD	O
O	O	1798	1801	not	not	I-VP	RB	O	49	VMOD	O
O	O	1802	1809	inhibit	inhibit	I-VP	VB	O	49	VC	O
T30	B-Protein	1810	1813	Tax	Tax	B-NP	NN	B-protein	53	NMOD	B-protein
O	O	1814	1823	induction	induction	I-NP	NN	O	51	OBJ	O
O	O	1824	1826	of	of	B-PP	IN	O	53	NMOD	O
T43	B-Entity	1827	1829	NF	NF	B-NP	NN	B-protein	57	NMOD	B-protein
T43	I-Entity	1829	1830	-	-	B-NP	HYPH	I-protein	57	NMOD	I-protein
T43	I-Entity	1830	1836	kappaB	kappaB	I-NP	NN	I-protein	54	PMOD	I-protein
O	O	1836	1837	.	.	O	.	O	13	P	O

O	O	1838	1846	Together	Together	B-ADVP	RB	O	5	VMOD	O
O	O	1846	1847	,	,	O	,	O	5	P	O
O	O	1848	1853	these	these	B-NP	DT	O	4	NMOD	O
O	O	1854	1861	studies	study	I-NP	NNS	O	5	SUB	O
O	O	1862	1873	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	1874	1878	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	1879	1883	HTLV	HTLV	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	1883	1884	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	1884	1885	1	1	I-NP	CD	O	10	NMOD	O
T31	B-Protein	1886	1889	Tax	Tax	I-NP	NN	B-protein	11	SUB	B-protein
O	O	1890	1898	exploits	exploit	B-VP	VBZ	O	6	SBAR	O
O	O	1899	1900	a	a	B-NP	DT	O	14	NMOD	O
O	O	1901	1907	distal	distal	I-NP	JJ	O	14	NMOD	O
O	O	1908	1912	part	part	I-NP	NN	O	11	OBJ	O
O	O	1913	1915	of	of	B-PP	IN	O	14	NMOD	O
O	O	1916	1919	the	the	B-NP	DT	O	20	NMOD	O
O	O	1920	1935	proinflammatory	proinflammatory	I-NP	JJ	B-protein	20	NMOD	B-protein
O	O	1936	1944	cytokine	cytokine	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	1945	1954	signaling	signaling	I-NP	NN	O	20	NMOD	O
O	O	1955	1962	cascade	cascade	I-NP	NN	O	15	PMOD	O
O	O	1963	1970	leading	lead	B-VP	VBG	O	20	NMOD	O
O	O	1971	1973	to	to	B-PP	TO	O	21	VMOD	O
O	O	1974	1983	induction	induction	B-NP	NN	O	22	PMOD	O
O	O	1984	1986	of	of	B-PP	IN	O	23	NMOD	O
T44	B-Entity	1987	1989	NF	NF	B-NP	NN	B-protein	27	NMOD	B-protein
T44	I-Entity	1989	1990	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T44	I-Entity	1990	1996	kappaB	kappaB	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	1996	1997	.	.	O	.	O	5	P	O

O	O	1998	2001	The	The	B-NP	DT	O	3	NMOD	O
O	O	2002	2014	pathological	pathological	I-NP	JJ	O	3	NMOD	O
O	O	2015	2025	alteration	alteration	I-NP	NN	O	16	SUB	O
O	O	2026	2028	of	of	B-PP	IN	O	3	NMOD	O
O	O	2029	2033	this	this	B-NP	DT	O	7	NMOD	O
O	O	2034	2042	cytokine	cytokine	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	2043	2050	pathway	pathway	I-NP	NN	O	4	PMOD	O
O	O	2051	2058	leading	lead	B-VP	VBG	O	7	NMOD	O
O	O	2059	2061	to	to	B-PP	TO	O	8	VMOD	O
T45	B-Entity	2062	2064	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
T45	I-Entity	2064	2065	-	-	I-NP	HYPH	I-protein	12	NMOD	I-protein
T45	I-Entity	2065	2071	kappaB	kappaB	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	2072	2082	activation	activation	I-NP	NN	O	9	PMOD	O
O	O	2083	2085	by	by	B-PP	IN	O	13	NMOD	O
T32	B-Protein	2086	2089	Tax	Tax	B-NP	NN	B-protein	14	PMOD	B-protein
O	O	2090	2093	may	may	B-VP	MD	O	0	ROOT	O
O	O	2094	2098	play	play	I-VP	VB	O	16	VC	O
O	O	2099	2100	a	a	B-NP	DT	O	20	NMOD	O
O	O	2101	2108	central	central	I-NP	JJ	O	20	NMOD	O
O	O	2109	2113	role	role	I-NP	NN	O	17	OBJ	O
O	O	2114	2116	in	in	B-PP	IN	O	17	VMOD	O
O	O	2117	2121	HTLV	HTLV	B-NP	NN	O	27	NMOD	O
O	O	2121	2122	-	-	B-NP	HYPH	O	27	NMOD	O
O	O	2122	2123	1	1	I-NP	CD	O	26	AMOD	O
O	O	2123	2124	-	-	I-NP	HYPH	O	26	P	O
O	O	2124	2132	mediated	mediate	I-NP	VBN	O	27	NMOD	O
O	O	2133	2147	transformation	transformation	I-NP	NN	O	21	PMOD	O
O	O	2148	2150	of	of	B-PP	IN	O	27	NMOD	O
O	O	2151	2156	human	human	B-NP	JJ	B-cell_type	31	NMOD	B-cell_type
O	O	2157	2158	T	T	I-NP	NN	I-cell_type	31	NMOD	I-cell_type
O	O	2159	2164	cells	cell	I-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	2164	2165	,	,	O	,	O	17	P	O
O	O	2166	2176	clinically	clinically	B-VP	RB	O	34	VMOD	O
O	O	2177	2187	manifested	manifest	I-VP	VBN	O	17	VMOD	O
O	O	2188	2190	as	as	B-PP	IN	O	34	VMOD	O
O	O	2191	2194	the	the	B-NP	DT	O	41	NMOD	O
O	O	2195	2200	adult	adult	I-NP	JJ	O	41	NMOD	O
O	O	2201	2202	T	T	I-NP	NN	O	41	NMOD	O
O	O	2202	2203	-	-	B-NP	HYPH	O	41	NMOD	O
O	O	2203	2207	cell	cell	I-NP	NN	O	41	NMOD	O
O	O	2208	2216	leukemia	leukemia	I-NP	NN	O	35	PMOD	O
O	O	2216	2217	.	.	O	.	O	16	P	O
